Compare Natera Inc. Common Stock (NTRA) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Prudential Financial Inc — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Prudential Financial Inc trades at $113.5 (market cap $39.13B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Prudential Financial Inc pays a 4.94% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Prudential Financial Inc for 146 Days on average.
| NTRA | PRU | |
|---|---|---|
Market Cap | $57.03B | $39.13B |
Volume | 1,131,157 | 1,369,167 |
Sector | Health | Financials |
52-Week High | $425.64 | $125.13 |
52-Week Low | $179.42 | $92.00 |
Typical Hold Time | 0 Days | 146 Days |
Enterprise Value | $56.18B | $67.90B |
Dividend Yield | — | 4.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Prudential Financial (PRU) trades at $113.49, showing minimal daily movement (+0.09%). The stock presents mixed signals with bearish technical indicators but fundamentally attractive valuation metrics including a P/E of 10.28 and P/S of 0.61. Recent earnings show two consecutive quarterly beats, while the company executes strategic initiatives including a $185 million Alexforbes stake sale and rebranding to Prudential Wealth Advisors.
PRU offers value investment appeal with strong profitability metrics (12.46% ROE) and dividend income potential, though facing headwinds from bearish technical trends and mixed analyst sentiment. The company's strategic focus on core businesses and cost reduction provides upside potential, while interest rate sensitivity and competitive pressures remain key monitoring points for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
